These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19674244)

  • 1. Relation between door-to-balloon time and microvascular perfusion as evaluated by myocardial blush grade, corrected TIMI frame count, and ST-segment resolution in treatment of acute myocardial infarction.
    Lee CH; Tai BC; Lau C; Chen Z; Low AF; Teo SG; Tan HC
    J Interv Cardiol; 2009 Oct; 22(5):437-43. PubMed ID: 19674244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of corrected thrombolysis in myocardial infarction frame count and ST-segment resolution to myocardial tissue perfusion after acute myocardial infarction.
    Li CM; Zhang XH; Ma XJ; Zhu XL
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):312-7. PubMed ID: 18288744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts.
    Kaltoft A; Bøttcher M; Sand NP; Rehling M; Andersen NT; Zijlstra F; Nielsen TT
    Am Heart J; 2006 May; 151(5):1108-14. PubMed ID: 16644346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.
    McCabe JM; Armstrong EJ; Hoffmayer KS; Bhave PD; MacGregor JS; Hsue P; Stein JC; Kinlay S; Ganz P
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):672-9. PubMed ID: 22949494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study.
    Shiomi H; Nakagawa Y; Morimoto T; Furukawa Y; Nakano A; Shirai S; Taniguchi R; Yamaji K; Nagao K; Suyama T; Mitsuoka H; Araki M; Takashima H; Mizoguchi T; Eisawa H; Sugiyama S; Kimura T;
    BMJ; 2012 May; 344():e3257. PubMed ID: 22623632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
    De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty.
    Bellandi F; Leoncini M; Maioli M; Toso A; Gallopin M; Piero Dabizzi R
    Clin Cardiol; 2004 Dec; 27(12):683-8. PubMed ID: 15628110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.
    De Luca G; Suryapranata H; de Boer MJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Ernst N; van 't Hof AW;
    Int J Cardiol; 2007 Apr; 117(2):232-7. PubMed ID: 16899313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction during off hours: the Mayo Clinic STEMI protocol.
    Holmes DR; Bell MR; Gersh BJ; Rihal CS; Haro LH; Bjerke CM; Lennon RJ; Lim CC; Ting HH
    JACC Cardiovasc Interv; 2008 Feb; 1(1):88-96. PubMed ID: 19393151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction.
    Greaves K; Dixon SR; Fejka M; O'Neill WW; Redwood SR; Marber MS; Senior R
    Heart; 2003 Feb; 89(2):139-44. PubMed ID: 12527661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic and electrocardiographic parameters of myocardial reperfusion in angioplasty of patients with ST elevation acute myocardial infarction loaded with ticagrelor or clopidogrel (MICAMI-TICLO trial).
    Winter JL; Lindefjeld DS; Veas N; Guarda E; Valdebenito M; Méndez M; Pérez O; Zuanic K; Mestas M; Martínez A
    Cardiovasc Revasc Med; 2014; 15(5):284-8. PubMed ID: 25178668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention.
    Porto I; Biasucci LM; De Maria GL; Leone AM; Niccoli G; Burzotta F; Trani C; Tritarelli A; Vergallo R; Liuzzo G; Crea F
    Eur Heart J; 2012 Dec; 33(23):2928-38. PubMed ID: 22453653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.
    De Luca G; van 't Hof AW; de Boer MJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Zijlstra F; Suryapranata H
    Eur Heart J; 2004 Jun; 25(12):1009-13. PubMed ID: 15191770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion.
    Piscione F; Danzi GB; Cassese S; Esposito G; Cirillo P; Galasso G; Rapacciuolo A; Leosco D; Briguori C; Varbella F; Tuccillo B; Chiariello M
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):715-21. PubMed ID: 19937780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
    Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
    J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Hudson MP; Armstrong PW; O'Neil WW; Stebbins AL; Weaver WD; Widimsky P; Aylward PE; Ruzyllo W; Holmes D; Mahaffey KW; Granger CB
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):183-92. PubMed ID: 21304097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.